Food and Drug Administration

First Page		Document Content
Date: 2005-06-20 14:31:16 Pharmaceutical sciences Clinical research Design of experiments Carbamates Food and Drug Administration Tipranavir Ritonavir Clinical trial Chemistry Protease inhibitors Pharmacology		Food and Drug Administration Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 61,87 KB Share Document on Facebook

	Notice : information de l’utilisateur Aptivus 250 mg capsules molles tipranavir Veuillez lire attentivement cette notice avant de prendre ce médicament car elle contient des informations importantes pour vous. Gardez DocID: 1lrxO - View Document
	Bijsluiter: informatie voor de gebruiker Aptivus 250 mg zachte capsules tipranavir Lees goed de hele bijsluiter voordat u dit geneesmiddel gaat innemen want er staat belangrijke informatie in voor u. Bewaar deze bijsluit DocID: 1kvu8 - View Document
	APTIVUS Soft Capsules Tipranavir Consumer Medicine Information (CMI) What is in this leaflet This leaflet answers some common DocID: 1gAFE - View Document
	PDF Document DocID: RNxu - View Document
	AIDS InfoNet www.aidsinfonet.org Fact Sheet Number 443 SAQUINAVIR (Invirase) DocID: RFm3 - View Document